Literature DB >> 11827138

A method for analytically generating three-dimensional isocomfort workspace based on perceived discomfort.

Dohyung Kee1.   

Abstract

The purpose of this study was to develop a new method for analytically generating three-dimensional isocomfort workspace for the upper extremities using the robot kinematics. Subjective perceived discomfort scores in varying postures for manipulating four types of controls were used. Fifteen healthy male subjects participated in the experiment. The subjects were asked to hold the given postures manipulating controls for 60 s in the seated position, and to rate their perceived discomfort during the following rest of 60 s using the magnitude estimation. Postures of the upper extremities set by shoulder and elbow motions, types of controls, and left right hand were selected as experimental variables, in which the L32 orthogonal array was adopted. The results showed that shoulder flexion and adduction-abduction, elbow flexion, and types of controls significantly affected perceived discomfort for postures operating controls, but hand used for operating controls did not. Depending upon the types of controls, four regression models predicting perceived discomfort were presented. Using the models, a sweeping algorithm to generate three-dimensional isocomfort workspace was developed, in which the robot kinematics was employed to describe the translational relationships between the upper arm and the lower arm/hand. It is expected that the isocomfort workspace can be used as a valuable design guideline when ergonomically designing three-dimensional workplaces.

Entities:  

Mesh:

Year:  2002        PMID: 11827138     DOI: 10.1016/s0003-6870(01)00047-3

Source DB:  PubMed          Journal:  Appl Ergon        ISSN: 0003-6870            Impact factor:   3.661


  1 in total

1.  Preventing Work-Related Musculoskeletal Disorders in Manufacturing by Digital Human Modeling.

Authors:  Jerzy Grobelny; Rafał Michalski
Journal:  Int J Environ Res Public Health       Date:  2020-11-22       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.